Publication | Closed Access

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyPharmacologyMyeloid NeoplasiaPharmacotherapyAnti-cancer AgentOncologyRadiation OncologySynergistic Cytotoxic ResponseHealth Sciences